Our research revealed that CYTOR dramatically decreased the expression of PPARA, a key regulator of lipid homeostasis.[89] It is hypothesized that CYTOR may control FA metabolism in ccRCC via reducing the expression of PPARA. The gene discussed is PPARA; the disease is nonpapillary renal cell carcinoma.